Ergasheva Gulshan Tokhirovna 2026. BREAKTHROUGH THERAPIES IN TYPE 2 DIABETES: ADVANCED ROLE OF GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS. International Multidisciplinary Journal for Research & Development. 13, 4 (Apr. 2026), 882–885.